Stock Research for NLNK

NLNK

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

NLNK Stock Chart & Research Data

The NLNK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the NLNK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


NLNK Due diligence Resources & Stock Charts

The NLNK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View NLNK Detailed Price Forecast - CNN Money CNN View NLNK Detailed Summary - Google Finance
Yahoo View NLNK Detailed Summary - Yahoo! Finance Zacks View NLNK Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View NLNK Trends & Analysis - Trade-Ideas Barrons View NLNK Major Holders - Barrons
NASDAQ View NLNK Call Transcripts - NASDAQ Seeking View NLNK Breaking News & Analysis - Seeking Alpha
Spotlight View NLNK Annual Report - CompanySpotlight.com OTC Report View NLNK OTC Short Report - OTCShortReport.com
TradeKing View NLNK Fundamentals - TradeKing Charts View NLNK SEC Filings - Bar Chart
WSJ View Historical Prices for NLNK - The WSJ Morningstar View Performance/Total Return for NLNK - Morningstar
MarketWatch View the Analyst Estimates for NLNK - MarketWatch CNBC View the Earnings History for NLNK - CNBC
StockMarketWatch View the NLNK Earnings - StockMarketWatch MacroAxis View NLNK Buy or Sell Recommendations - MacroAxis
Bullish View the NLNK Bullish Patterns - American Bulls Short Pains View NLNK Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View NLNK Stock Mentions - StockTwits PennyStocks View NLNK Stock Mentions - PennyStockTweets
Twitter View NLNK Stock Mentions - Twitter Invest Hub View NLNK Investment Forum News - Investor Hub
Yahoo View NLNK Stock Mentions - Yahoo! Message Board Seeking Alpha View NLNK Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for NLNK - SECform4.com Insider Cow View Insider Transactions for NLNK - Insider Cow
CNBC View NLNK Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for NLNK - OTC Markets
Yahoo View Insider Transactions for NLNK - Yahoo! Finance NASDAQ View Institutional Holdings for NLNK - NASDAQ


Stock Charts

FinViz View NLNK Stock Insight & Charts - FinViz.com StockCharts View NLNK Investment Charts - StockCharts.com
BarChart View NLNK Stock Overview & Charts - BarChart Trading View View NLNK User Generated Charts - Trading View




Latest Financial News for NLNK


NewLink Genetics to Host Its Fourth Quarter and Full Year 2018 Financial Results Conference Call on February 27, 2019
Posted on Thursday February 07, 2019

NewLink Genetics Corporation (NLNK) today announced that it will release its fourth quarter and full year 2018 financial results on Wednesday, February 27, 2019. NewLink Genetics' senior management team will host the conference call, which will be open to all listeners. The conference call will be webcast live and a link can be accessed through the NewLink Genetics website at https://edge.media-server.com/m6/p/dqg32drc.


Factors of Influence in 2019, Key Indicators and Opportunity within Marathon Oil, Accuray, United Natural Foods, Systemax, Amgen, and NewLink Genetics — New Research Emphasizes Economic Growth
Posted on Friday February 01, 2019

NEW YORK, Feb. 01, 2019 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.


NewLink Genetics to Participate in the Immuno-Oncology 360° Conference
Posted on Wednesday January 30, 2019

Dr. Link’s presentation, “IDO Changes the T-cell Balance in the Tumor Microenvironment,” will occur on Wednesday, February 6th, at 9:15 AM ET, and will include a discussion of immune regulation in the tumor microenvironment and how indoximod’s mechanism of action lends itself to counter multiple elements of immune regulation. NewLink Genetics is a clinical stage biopharmaceutical company focused on developing novel immuno-oncology product candidates to improve the lives of patients with cancer.


Before You Buy NewLink Genetics Corporation (NASDAQ:NLNK), Consider Its Volatility
Posted on Tuesday January 22, 2019

If you're interested in NewLink Genetics Corporation (NASDAQ:NLNK), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could Read More...


Stock Market & Investing Books

Enter a stock symbol to view the stock details.